Abstract
Skeletal scintigraphy provides a functional image of bone. It is a highly sensitive method that depicts early changes in bone flow and turnover. Because of this high sensitivity, skeletal scintigraphy allows early diagnosis of disease often days or weeks before disease can be visualized on anatomic imaging. Therefore, skeletal scintigraphy assists in establishing early treatment and hopefully achieving better patient outcomes. However, as with other nuclear medicine imaging procedures, this high sensitivity is generally accompanied by a low level of specificity. Information about early changes in blood flow and bone turnover cannot be obtained, or not easily obtained, by other imaging methods. Although the spatial resolution of bone scintigraphy is relatively low compared to anatomic imaging, one can say that its functional resolution is very high. Skeletal development and remodeling are integral parts of the physiology of bone. As the patient grows and develops, bone undergoes constant remodeling. Immature bone (woven bone) is replaced by mature lamellar bone. A skeletal scintigram can be considered not just as a static image but also as a “snapshot” of an ongoing dynamic process. As such, the bone scan can be thought of as a “slow dynamic” study. Approximately 10 % of the entire adult skeleton is replaced every year. Remodeling is a functional adaptation of bone to the forces or stresses of daily life. When interpreting pediatric skeletal scintigraphy, it is important to keep in mind the characteristic patterns of pediatric skeletal growth and development and learn to recognize these patterns so they can be distinguished from actual lesions. The distribution of bone-seeking radiopharmaceuticals varies with age and with the activity of growth centers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tilden RL, Jackson Jr J, Enneking WF, DeLand FH, McVey JT. 99m Tc-polyphosphate: histological localization in human femurs by autoradiography. J Nucl Med. 1973;14(8):576–8.
Subramanian G, McAfee JG, Bell EG, Blair RJ, O’Mara RE, Ralston PH. 99m Tc-labeled polyphosphate as a skeletal imaging agent. Radiology. 1972;102(3):701–4.
Subramanian G, McAfee JG, Blair RJ, Kallfelz FA, Thomas FD. Technetium-99m-methylene diphosphonate–a superior agent for skeletal imaging: comparison with other technetium complexes. J Nucl Med. 1975;16(8):744–55.
Gelfand MJ, Parisi MT, Treves ST. Pediatric radiopharmaceutical administered doses: 2010 North American consensus guidelines. J Nucl Med. 2011;52(2):318–22.
Blau M, Nagler W, Bender MA. Fluorine-18: a new isotope for bone scanning. J Nucl Med. 1962;3:332–4.
Grant FD, Fahey FH, Packard AB, Davis RT, Alavi A, Treves ST. Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med. 2008;49(1):68–78.
Grant FD, Drubach LA, Treves ST. 18F-Fluorodeoxyglucose PET and PET/CT in pediatric musculoskeletal malignancies. PET Clin. 2010;5(3):349–61.
Grant FD, Laffin SP, Davis RT, Drubach LA, Fahey FH, Treves ST. Skeletal PET with F-18 sodium fluoride as an alternative to Tc-99m bone SPECT in children. Pediatr Radiol. 2010;40(4):538.
Rosenfield N, Treves S. Osseous and extraosseous uptake of fluorine-18 and technetium-99m polyphosphate in children with neuroblastoma. Radiology. 1974;111(1):127–33.
Alazraki N, Dries D, Datz F, Lawrence P, Greenberg E, Taylor Jr A. Value of a 24-hour image (four-phase bone scan) in assessing osteomyelitis in patients with peripheral vascular disease. J Nucl Med. 1985;26(7):711–7.
Mawlawi O, Yahil A, Vija H, Erwin W, Macapinlac H. Reduction in scan duration or injected dose in planar bone scintigraphy enabled by Pixon(R) post-processing. Soc Nucl Med Annu Meet Abstr. 2007;48(Meeting Abstracts 2):13P-b.
Roach PJ, Connolly LP, Zurakowski D, Treves ST. Osteoid osteoma: comparative utility of high-resolution planar and pinhole magnification scintigraphy. Pediatr Radiol. 1996;26(3):222–5.
Taylor GA, Shea N, O’Brien T, Hall JE, Treves ST. Osteoid osteoma: localization by intraoperative magnification scintigraphy. Pediatr Radiol. 1986;16(4):313–6.
Blaskiewicz DJ, Sure DR, Hedequist DJ, Emans JB, Grant F, Proctor MR. Osteoid osteomas: intraoperative bone scan-assisted resection. Clinical article. J Neurosurg Pediatr. 2009;4(3):237–44.
Sokol L, Zurakowski D, D’Hemecourt P, Micheli L, Treves ST. Back pain in children less than 10 years of age: high incidence of abnormalities detected on skeletal single photon emission computed tomography (SPECT). Pediatr Radiol. 2010;40(4):539.
Sheehy N, Tetrault TA, Zurakowski D, Vija AH, Fahey FH, Treves ST. Pediatric 99mTc-DMSA SPECT performed by using iterative reconstruction with isotropic resolution recovery: improved image quality and reduced radiopharmaceutical activity. Radiology. 2009;251(2):511–6.
Stansfield EC, Sheehy N, Zurakowski D, Vija AH, Fahey FH, Treves ST. Pediatric 99mTc-MDP bone SPECT with ordered subset expectation maximization iterative reconstruction with isotropic 3D resolution recovery. Radiology. 2010;257(3):793–801.
Vija AH, Hawman EG, Engdahl JC. Analysis of a SPECT OSEM reconstruction method with 3D beam modeling and optional attenuation correction: phantom studies. Paper presented at Nuclear Science Symposium Conference Record, IEEE; 19–25 Oct 2003.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Treves, S.T. (2014). Skeletal Scintigraphy: General Considerations. In: Treves, S. (eds) Pediatric Nuclear Medicine and Molecular Imaging. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9551-2_15
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9551-2_15
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9550-5
Online ISBN: 978-1-4614-9551-2
eBook Packages: MedicineMedicine (R0)